Med Paper Reports Decline in Revenue Amidst Decreasing Debt

10:20

The Moroccan paper specialist Med Paper has reported a decline in its activity as of the end of June 2026. While revenues have decreased year-on-year, the company has significantly reduced its debt while maintaining its focus on development strategies in the domestic market.

Med Paper enters the second half of the year in a still constrained environment. As of the end of June 2026, the Moroccan paper manufacturer recorded a revenue of 39.015 million dirhams, down from 42.420 million dirhams during the same period in 2025.

This development reflects a decline in activity over the first six months of the fiscal year. The trend is also evident in the second quarter alone, during which revenues amounted to 21.781 million dirhams, compared to 23.419 million dirhams a year earlier.

A Declining Second Quarter

The slowdown observed throughout the semester continued between April and June.

According to its financial communication, Med Paper recorded no investments during the second quarter of 2026. The absence of new investments comes as the company operates in what it describes as a challenging environment.

However, this caution does not prevent the group from pursuing its strategic directions and seeking to consolidate its presence in the Moroccan market.

Debt Continues to Decline

The main positive point of the period concerns the debt situation.

At the end of the second quarter, it stood at 105.323 million dirhams, compared to 114.125 million dirhams during the same period in 2025. Med Paper thus reduced its debt level by approximately 8.8 million dirhams year-on-year.

This improvement provides the company with a supportive element even as its commercial activity remains under pressure.

Local Production at the Heart of the Strategy

Despite the decline in its revenues, Med Paper intends to continue its strategy and strengthen its position in the Moroccan market.

The company is particularly focused on the prospects related to the National Preferences Law, which aims to enhance the consideration of domestic offerings in certain orders and procurement procedures.

Med Paper views this framework as a lever that could support Moroccan industrial players. In this context, the company expresses confidence in the opportunities presented by its domestic market.

The first half of 2026 thus presents a mixed picture: declining activity, but better-managed debt and prospects that the company considers favorable in the Moroccan market.